An acquired loss of renal DNaseI has recently been shown to promote transformation of mild mesangial lupus nephritis into membrano-proliferative end-stage organ disease. In this study, we analyzed expression profiles of DNaseI in other organs of lupus-prone (NZBxNZW)F1 mice during disease progression to determine if silencing of the renal DNaseI gene is an organ specific feature or if loss of DNaseI reflects a systemic error in mice with sever lupus nephritis. Our results demonstrate normal or elevated levels of DNaseI mRNA and enzyme activity in liver, spleen and serum samples of (NZBxNZW)F1 mice throughout all stages of lupus nephritis. DNaseI activity was dramatically reduced only in kidneys of mice with sever nephritis and was the only nuclease that was down-regulated, while 6 other nucleases (DNaseIl1-3, caspase activated deoxyribonuclease, Dnase2a, and endonuclease G) were largely normally expressed in kidneys, liver and spleen. Loss of renal DNaseI was not accompanied by changes in serum DNaseI activity, suggesting an independent mechanism of DNaseI regulation in circulation and in kidneys, and an absence of compensatory upregulation of serum DNaseI activity in case of renal DNaseI deficiency. Thus, silencing of renal DNaseI is a unique renal feature in membrano-proliferative lupus nephritis.
Introduction consumption during nephritis. Therefore, it became important to verify if silencing of the renal DNaseI gene is an organ specific feature or if it reflects a systemic error in BW mice with sever lupus nephritis.
The aim of the present study was, therefore, to determine i. whether loss of renal DNaseI is unique to the kidney, or occurs simultaneously in other organs as well, ii. whether silencing of renal DNaseI is a selective process not involving other nucleases in defined stages of the disease; and iii. whether there is any compensatory up-regulation of DNaseI or other nucleases in kidneys and other organs.
In this study we examined DNaseI expression in kidneys, livers and spleens of BW mice at different stages of lupus nephritis. This allowed us to analyze for deviations in DNaseI levels in one organ with strongly (liver) and another organ with marginally detectable DNaseI (spleen). Published data have demonstrated that liver is the main source for serum DNaseI 16 while in spleen, the level of the DNaseI is very low in a physiological context.
17,18
Both organs are also responsible for clearance of circulating immune-complexes (IC) 19, 20 and participate in the pathogenesis of lupus nephritis in a case of defective chromatin degradation.
Therefore, data described in this study are important to inform whether the processes observed in the kidney are unique for DNaseI and for the kidney, or represent systemic errors globally in the body.
Our results demonstrate that renal DNaseI is reduced strictly in membranoproliferative (end-stage) nephritis, and is the only nuclease that is down-regulated among 7
analyzed nucleases (DNaseI, DNaseIl1-3, caspase activated deoxyribonuclease (CAD), Dnase2a, and endonuclease G (EndoG)). While dramatically reduced in the kidneys, DNaseI is not reduced in the spleen or in the liver. We observed no significant down-or up-regulation of any of the other 6 nucleases in the examined organs. These data and the background for them may point at mechanisms responsible for silencing of the DNaseI gene as a future causal therapeutic target to treat and prevent progressive lupus nephritis.
Materials and Methods

Animals
Female BW and BALB/c mice were purchased from Harlan (Blackthorn, UK). Treatment and care of animals were in accordance with the guidelines of The Norwegian Ethical and Welfare
Board for Research Animals, and the study was approved by the Institutional Review Board.
Collection of samples from groups of mice
Serum samples from BW mice were collected from pre-nephritic mice (Group 1, n=3), mice with mesangial nephritis (Group 2, n=3), and from mice with membrano-proliferative nephritis (Group 3, n=6). Sera were stored at -20°C. Degree of proteinuria was monitored weekly with sticks from Bayer Diagnostics (Bridgend, UK). Animals were euthanized by CO 2 -suffocation. Kidneys, livers and spleens were extirpated, cut, and fixed in RNAlater (Qiagen Nordic, Norway) for further analysis of gene transcription, or fixed in 4% buffered depolymerized paraformaldehyde and embedded in paraffin for immunohistochemical analysis, or fixed in 8% buffered depolymerized paraformaldehyde for immune electron microscopy (kidneys and livers only). 21 The same samples were collected from sex-and agematched BALB/c control mice.
Anti-dsDNA Enzyme-Linked Immunosorbent Assay
Murine anti-dsDNA antibodies were detected and titrated by standard indirect ELISA, as described in details.
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Immune Electron Microscopy
Immune electron microscopy (IEM) was performed on murine kidney and liver sections exactly as described previously. 21 In short, sections were incubated with rabbit anti-mouse 
Immunoexpression score
To evaluate the degree of protein expression we blindly quantified the intensity of staining in 
Gene Expression Analysis
Total RNA was isolated with EZ-1 RNA tissue mini kit (Qiagen). The gel was incubated in a humidified chamber at 37°C for 17 hours and photographed under UV illumination.
Denaturing SDS-PAGE zymography (DPZ).
DNaseI activity in the kidneys, livers and sera was determined after protein separation in a 10% SDS-polyacrylamide gel containing 40 μg/ml heat-denatured salmon sperm DNA (Invitrogen Corp, Carlsbad, CA) as described.
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Native PAGE zymography (NPZ)
In order to analyze for DNaseI in the spleens, we also performed the more sensitive native PAGE zymography instead of SDS-PAGE. 16 DNaseI activity was determined after protein separation in 7.5% polyacrylamide gels containing 30 μg/ml heat-denatured salmon sperm DNA (Invitrogen) as described in details elsewhere. 16, 17 Liver samples were analyzed by SDS-and native PAGE zymographies, both techniques demonstrated similar results in liver tissue.
Statistical Analysis
One-way analysis of variance with Dunett post hoc test was used in this study. Differences were regarded significant at p < 0.05. Figure 1 upper panels and Table 1 ). Liver tissue of animals from each group was also analyzed by IEM. We did not find any immune deposits or electron dense structures in liver capillary and arterial walls in any of the mice included in this study (Table1, Figure 1 lower panels). Sex and age matched BALB/c mice were used as healthy control mice. They were all negative for anti-DNA antibodies and did not have any immune deposits in kidneys or livers (data not shown).
Results
Analysis
DNaseI expression in kidneys, livers, spleens and sera of BW mice.
Relative DNaseI gene expression levels in different organs from Group 1-3 mice was analyzed by real time PCR, corresponding enzyme activity and protein expression. Figure 3D ), total nuclease activity was not reduced during lupus nephritis progression, similar to the results of DNaseI zymography on serum samples shown in Figure   2D .
Expression profiles of other nucleases in kidneys, livers and spleens from Group 1-3 BW mice.
We measured gene expression levels of other endonucleases by real time PCR applied to 
Discussion
The role of reduced DNaseI in the pathogenesis of SLE has been discussed for decades. This may indeed be one of the factors that result in impaired clearance of apoptotic, secondary necrotic cell debris.
36-39
Interestingly, we found increased DNaseI mRNA level and enzyme activity in liver and in spleen in early and late stages of nephritis. The observed increase of DNaseI expression in those organs was associated with high titers of serum anti-dsDNA antibodies.
Since one common function of liver and spleen is uptake of circulating immune complexes we assume that DNaseI may participate in chromatin degradation of cleared IC. This may eventually explain increased DNaseI expression in these organs.
Selective loss of renal DNaseI creates a basis for in situ deposition of chromatin, a phenomenon independently demonstrated in different experimental nuclease deficiencies. In several of such studies, it is demonstrated that chromatin fragments accumulates in situ where it is released from dead cells (reviewed in 40 ) instead of entering circulation, which would eventually promote deposition in distant organs as well.
The present results add weight to the assumption that DNaseI shut-down is secondary to early anti-dsDNA antibody-mediated deposition of immune complexes in the mesangial matrix. 8 This may mean that inflammation linked to (silent or mild) mesangial nephritis in fact impose the loss of renal DNaseI with the consequences for renal function as described
here. This proposed mechanism is in agreement with results of high resolution techniques to determine the nature of target structures within the glomeruli. These structures appear as electron-dense structures (EDS) by transmission electron microscopy (TEM), and have been shown to be composed of chromatin fragments and IgG molecules by different forms of immune electron microscopy and by co-localization terminal deoxy-nucleotidyl-transferase (TdT) biotin-dUTP nicked end-labeled (TUNEL) IEM assay. [41] [42] [43] Comparative studies of components and localization of EDS in skin and glomeruli in SLE demonstrated that they are composed of similar chromatin-related structures. 41, 42 Deposition of ICs in glomeruli did not, however, predict deposition in skin. 41, 42 Examination of DNaseI expression in skin of MRL-lpr/lpr and BW mice has demonstrated stable DNaseI activity during development of lupus nephritis. 42 Those results indicate that chromatin-IgG complexes that deposits in skin have another origin than from skin itself. In harmony with this published data demonstrate presence of polyomovirus large T antigen in extra-cellular chromatin associated with glomerular and skin membranes, 41 suggesting that chromatin fragments in both kidneys and skin might derive from polyomovirus-infected renal cells since renal polyomovirus infection is a frequent finding in patients with lupus nephritis. 
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Kidney Liver Figure 1 . Immune electron microscopy analyses of electron-dense structures (EDS) in kidneys and livers from BW mice at different stages of lupus nephritis. BW mice were divided into 3 groups according to kidney morphology (upper panels): Group 1 -mice without EDS in glomeruli; Group 2 -animals with immune deposits in mesangium; Group 3 -mice with deposition in both mesangial matrix and glomerular basement membranes. In-vivo bound IgG are traced by 5 nm gold particles. No EDS was, however, found in arterial or capillary walls in corresponding liver sections in Group 1-3 BW mice (lower panels). 
